Chen Bihua

Director, 10% OwnerBridgeBio Oncology Therapeutics, Inc. (BBOT) · full profile →Form 4 · filed Aug 13, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
10
8 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 11, 2025Disposed to issuer(D)153K$04.5M
Aug 11, 2025Option exercise(M)4.2M4.7M
Aug 11, 2025Grant(A)760K$10.72$8.2M2.2M
Aug 11, 2025Grant(A)285K6.0M
Aug 11, 2025Grant(A)1.8M3.3M
Aug 11, 2025Grant(A)1.9M1.9M
Aug 11, 2025Grant(A)5.6M$10.72$60.0M5.7M
Aug 11, 2025Grant(A)639K$10.72$6.9M1.5M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 11, 2025Disposed to issuer(D)308K$04.2M
Aug 11, 2025Option exercise(M)4.2M0

Transaction Codes

D
Disposition to the issuer
M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-25-075305) within minutes of acceptance. Every field above traces to the original document. Verify it directly: